A diagnosis of colon cancer can raise an important question, especially when several relatives have had the disease: Could colon cancer be inherited?
The answer is sometimes yes. While most colorectal cancers are not caused by a single inherited gene change, some are linked to hereditary cancer syndromes. Lynch syndrome is the most common inherited colorectal cancer syndrome and can significantly increase the risk of colorectal and other cancers.
Understanding your family history can help identify whether you may need earlier or more frequent screening, genetic counselling, or genetic testing.
At Chirag Global Hospitals, Bangalore, discussing your family history with a colorectal specialist can be an important first step towards deciding what evaluation may be appropriate for you.
Book a Consultation | Call 08065903127
What Is Lynch Syndrome?
Lynch syndrome is an inherited condition that increases the risk of developing colorectal cancer and certain other cancers.
It happens because of a harmful inherited change, also called a pathogenic variant, in genes involved in repairing mistakes that occur when DNA is copied. These are known as mismatch repair genes.
The main genes associated with Lynch syndrome are:
- MLH1
- MSH2
- MSH6
- PMS2
- EPCAM, which can affect MSH2 function
Normally, mismatch repair proteins help correct DNA errors. When this repair system does not work properly, genetic errors can accumulate over time, increasing the possibility of cancer.
Is Colon Cancer Hereditary?
Colon cancer can occur because of many different factors, including age, lifestyle, environmental factors, random genetic changes and inherited genetic susceptibility.
A family history of colon cancer does not automatically mean that you have Lynch syndrome.
However, an inherited cause may be more likely when there is a pattern such as:
- Colorectal cancer diagnosed at a relatively young age
- Several relatives with colorectal cancer
- Endometrial cancer or other Lynch-associated cancers in the family
- One person developing more than one type of cancer associated with Lynch syndrome
- A close relative who has already tested positive for a Lynch syndrome-related pathogenic variant
It is important to distinguish familial risk from a confirmed hereditary syndrome. A family may have several cases of colorectal cancer without a specific inherited mutation being identified.
What Cancers Are Linked to Lynch Syndrome?
Lynch syndrome is not limited to colon cancer.
Depending on the gene involved and other individual factors, people with Lynch syndrome may have an increased risk of:
- Colorectal cancer
- Endometrial cancer
- Ovarian cancer
- Stomach cancer
- Small intestine cancer
- Urinary tract cancers
- Certain pancreatic and biliary tract cancers
- Some brain tumours
- Certain sebaceous gland tumours
The level of risk is not identical for every person with Lynch syndrome. The specific gene variant, sex, age, family history and other factors can influence the overall risk.
This is why genetic counselling and an individualised screening plan are important.
What Are the Symptoms of Lynch Syndrome?
Lynch syndrome itself usually does not cause a specific symptom that you can recognise at home.
The concern is the increased risk of developing certain cancers.
Symptoms that can occur with colorectal cancer include:
- Blood in or on the stool
- A persistent change in bowel habits
- Ongoing constipation or diarrhoea
- Abdominal discomfort or cramping
- Unexplained weight loss
- Persistent fatigue
- Iron-deficiency anaemia without an obvious cause
These symptoms can have many causes and do not necessarily mean cancer.
However, persistent or unexplained symptoms should be evaluated by a healthcare professional, particularly when there is a strong family history of colorectal cancer.
How Is Lynch Syndrome Diagnosed?
Lynch syndrome evaluation usually involves more than one step.
Step 1: Review Your Personal and Family History
A doctor may ask about:
- Which relatives have had cancer
- The type of cancer they had
- Their age at diagnosis
- Whether the same person developed more than one cancer
- Whether genetic testing has previously been performed in the family
This information helps determine whether genetic evaluation may be appropriate.
Step 2: Tumour Testing
When colorectal or certain other cancers have already been diagnosed, the tumour may be tested for signs that the mismatch repair system is not functioning normally.
Two commonly used approaches are:
- Mismatch repair immunohistochemistry, or MMR IHC
- Microsatellite instability, or MSI, testing
A tumour showing mismatch repair deficiency, known as dMMR, or high microsatellite instability, known as MSI-H, may require further evaluation.
Importantly, an abnormal tumour test does not automatically prove that a person has inherited Lynch syndrome. Some tumours develop mismatch repair abnormalities for reasons unrelated to an inherited mutation.
Step 3: Germline Genetic Testing
If Lynch syndrome is suspected, genetic testing can look for an inherited pathogenic variant.
Testing may use a blood or saliva sample, depending on the testing approach.
Genetic counselling can help explain what the results mean before and after testing.
What Does a Positive Lynch Syndrome Test Mean?
A positive genetic test means that an inherited pathogenic variant associated with Lynch syndrome has been identified.
It does not mean that cancer is inevitable.
It means the person’s risk is higher than that of the general population and that a more focused cancer surveillance plan may be appropriate.
Lynch syndrome is usually inherited in an autosomal dominant pattern. If a parent carries a pathogenic variant, each child has a 50% chance of inheriting that variant.
That 50% figure refers to inheriting the genetic variant, not a 50% certainty of developing cancer.
When a pathogenic variant is identified, close relatives may be offered genetic counselling and, where appropriate, targeted testing.
How Is Lynch Syndrome Managed?
There is no single screening plan that is suitable for everyone with Lynch syndrome.
Management may include:
- Earlier and more frequent colonoscopy
- Surveillance for other Lynch-associated cancers
- Genetic counselling
- Discussion of family testing
- Attention to symptoms that require prompt assessment
- Risk-reduction strategies based on the person’s individual situation
For people with confirmed Lynch syndrome, colonoscopy is generally performed more frequently than standard average-risk screening, often at intervals of around one to two years. The recommended starting age and interval can vary according to the specific gene, family history and current clinical guidelines.
Some people may also discuss preventive medicines or risk-reducing surgery with their healthcare team, depending on their individual cancer risks.
Lynch Syndrome vs Other Hereditary Colon Cancer Conditions
Lynch syndrome is not the only inherited condition associated with colorectal cancer.
For example, familial adenomatous polyposis, or FAP, is associated with the APC gene and can cause the development of numerous colorectal polyps.
Lynch syndrome is different. People with Lynch syndrome may not have hundreds of polyps, but they can have a substantially increased risk of colorectal cancer because of impaired DNA mismatch repair.
This distinction matters because the appropriate screening and management strategy depends on the underlying condition.
What Should You Do If Colon Cancer Runs in Your Family?
Do not assume that a family history means you will develop cancer. At the same time, do not ignore a strong or unusual pattern of cancer in your family.
Consider speaking with a doctor if:
- A parent, sibling or child has had colorectal cancer
- A relative was diagnosed with colorectal cancer at a young age
- Several relatives have had colorectal or related cancers
- Your family has a known Lynch syndrome mutation
- You have had colorectal cancer at a younger-than-usual age
- You have developed more than one cancer associated with Lynch syndrome
A doctor can review your history and determine whether earlier screening, tumour testing, genetic counselling or genetic testing should be considered.
Can Lynch Syndrome Be Prevented?
The inherited genetic change itself cannot be prevented. However, identifying Lynch syndrome can allow cancer risk to be managed more proactively.
Regular surveillance can help doctors detect colorectal abnormalities earlier. In some circumstances, polyps can be removed during colonoscopy before they develop into cancer.
Knowing about Lynch syndrome can also help family members understand whether they may need genetic counselling or earlier screening.
The goal is not to create unnecessary anxiety. It is to replace uncertainty with appropriate risk assessment and a clear follow-up plan.
The Importance of Knowing Your Family History
Your family history is an important part of your health information.
Try to record:
- Cancer types diagnosed in close relatives
- Approximate ages at diagnosis
- Whether relatives had more than one cancer
- Previous genetic test results, if available
- Any known hereditary cancer diagnosis in the family
Even incomplete information can be useful when you discuss your risk with a doctor.
For people with a strong family history, recognising the possibility of Lynch syndrome may lead to earlier evaluation and a more appropriate colorectal cancer screening strategy.
When Should You Speak to a Specialist?
You do not need to wait for symptoms before discussing hereditary cancer risk.
Consider a consultation if you have a significant family history of colorectal or related cancers, especially when cancers occurred at younger ages or affected several close relatives.
A specialist can help distinguish between routine screening needs and situations that may warrant further genetic or colorectal evaluation.
Chirag Global Hospitals provides colorectal and proctology care in Bangalore, with assessment and management for colon and rectal conditions.
Concerned about a family history of colon cancer or possible Lynch syndrome? Consult the colorectal care team at Chirag Global Hospitals, Bangalore, to review your risk and discuss suitable screening or diagnostic next steps.
Medical note: This article is intended for general education and should not replace an individual medical consultation, genetic counselling or a doctor’s screening recommendation.
FAQs
What is Lynch syndrome?
Lynch syndrome is an inherited condition caused by pathogenic variants affecting DNA mismatch repair. It increases the risk of colorectal cancer and several other cancers.
Does Lynch syndrome mean I will get colon cancer?
No. Having Lynch syndrome increases the risk of colorectal cancer, but it does not mean that cancer is inevitable. Regular surveillance can help manage the increased risk.
How do I know if colon cancer runs in my family?
A pattern of colorectal cancer among close relatives, particularly at younger ages, or a combination of colorectal and related cancers may suggest inherited risk. A doctor or genetic counsellor can assess your family history more accurately.
What genes cause Lynch syndrome?
The main genes associated with Lynch syndrome are MLH1, MSH2, MSH6 and PMS2. EPCAM alterations can also cause Lynch syndrome through their effect on MSH2.
How is Lynch syndrome tested?
Evaluation may begin with a review of personal and family history. Tumour testing using MMR immunohistochemistry or MSI testing may be followed by germline genetic testing when appropriate.
If my parent has Lynch syndrome, can I inherit it?
Yes. Lynch syndrome is generally inherited in an autosomal dominant pattern. If one parent carries a pathogenic variant, each child has a 50% chance of inheriting that variant. This does not mean a 50% certainty of developing cancer.
How often should someone with Lynch syndrome have a colonoscopy?
People with confirmed Lynch syndrome generally need colonoscopy more frequently than people at average risk, often every one to two years. The recommended starting age and interval depend on the specific gene, family history and clinical guidelines.
Can Lynch syndrome affect cancers other than colon cancer?
Yes. Lynch syndrome can increase the risk of several cancers, including endometrial, ovarian, stomach, small intestine and urinary tract cancers. The specific risks vary according to the gene and individual factors.
